FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Medtronic Receives CE Mark for Thoracic Stent Graft

Nov. 15, 2018

Medtronic received a CE Mark for its Valiant Navion thoracic stent graft, used to repair lesions in the descending aorta.

The stent graft is intended for use in minimally invasive therapies to treat a variety of aortic conditions, including thoracic aortic aneurysms, blunt traumatic aortic injuries, intramural hematomas and type B aortic dissections.

The device is a low-profile version of the company’s Captivia thoracic stent system and allows patients with small iliac arteries to undergo thoracic endovascular aneurysm repairs.

View today's stories